References
- Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, . 2010. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med 2:54–76.
- Barzon L, Zanusso M, Colombo F, Palù G. 2006. Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther 13:539–554.
- Burmeister M, McInnis MG, Zöllner S. 2008. Psychiatric genetics: progress amid controversy. Nat Rev Genet 9:527–540.
- Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. 2010. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 107:22687–22692.
- Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, . 1998. Regulation of cocaine reward by CREB. Science 282:2272–2275.
- Carty NC, Nash K, Lee D, Mercer M, Gottschall PE, Meyers C, . 2008. Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. Mol Ther 16:1580–1586.
- Chen G, Twyman R, Manji HK. 2010. p11 and gene therapy for severe psychiatric disorders: a practical goal? Sci Transl Med 2:54ps51.
- Kaplitt MG. 2009. Gene therapy clinical trials in the human brain. Protocol development and review of current applications. Front Neurol Neurosci 25:180–188.
- Lesch KP. 1999. Gene transfer to the brain: emerging therapeutic strategy in psychiatry? Biol Psychiatry 45:247–253.
- Martinez-Serrano A, Rubio FJ, Navarro B, Bueno C, Villa A. 2001. Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. Curr Gene Ther 1:279–299.
- Neumaier JF. 2003. Gene therapy in psychiatric disorders: too early, too complex? Curr Opin Pharmacol 3:68–72.
- Ocaranza P, Quintanilla ME, Tampier L, Karahanian E, Sapag A, Israel Y. 2008. Gene therapy reduces ethanol intake in an animal model of alcohol dependence. Alcohol Clin Exp Res 32:52–57.
- Russo SJ. 2008. The potential for viral gene therapy in psychiatry. Am J Psychiatry 165:675.
- Sapolsky RM. 2003. Gene therapy for psychiatric disorders. Am J Psychiatry 160:208–220.
- Seshadri AJ, Hayashi-Takagi A. 2009. Gene manipulation with stereotaxic viral infection for psychiatric research: spatiotemporal components for schizophrenia. Prog Brain Res 179:17–27.
- Spencer B, Marr RA, Rockenstein E, Crews L, Adame A, Potkar R, . 2008. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioural improvement in APP transgenic mice. BMC Neursci 9:109.